Sign in

CIK 0001609809

  • Non-accelerated filer
  • Smaller reporting company

Seres Therapeutics, Inc.

Sign in to watch
Ticker
MCRB
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
274326290
Phone
+1 617-945-9626
Business address
200 SIDNEY STREET, CAMBRIDGE, MA, 02139
Former names
Seres Therapeutics, Inc., Seres Health, Inc.
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 3 Insider Initial Statement of Ownership
  9. 4 Open-market sale Ege David S. sold 5,012 shares at $7.93 ($39,745)
  10. 4 Grant or award Chief Financial Officer acquired 42,500 shares (grant or award)
  11. 4 Derivatives Options or other derivatives
  12. 3 Insider Initial Statement of Ownership
  13. 4 Open-market buy 10% owner bought 8,738,243 shares at $3.15 ($27,525,465)
  14. 4 Grant or award Chief Legal Officer and EVP acquired 63,492 shares (grant or award)
  15. 4 Grant or award Henn Matthew R. acquired 47,619 shares (grant or award)
  16. 4 Grant or award Cloghessy Paula acquired 31,746 shares (grant or award)
  17. 4 Grant or award Chief Financial Officer acquired 63,492 shares (grant or award)
  18. 4 Grant or award Director acquired 63,492 shares (grant or award)
  19. 4 Grant or award Ege David S. acquired 31,746 shares (grant or award)
  20. 4 Grant or award Director acquired 31,746 shares (grant or award)

Page 8 of 19 · 380 filings